News

CSIR-IICT developed Favipiravir API transferred to Cipla for scale-up and production

CSIR-IICT has developed a cost effective process using locally available chemicals to synthesize this API and has transferred the technology to Cipla

Jul 28, 2020

By : Team ABLE

IIT Kharagpur researchers develop novel technology for COVID-19 rapid testing

The entire rapid test can be conducted in an ultra-low-cost portable device with the test results available in a customized smartphone application for dissemination within 1 hour

Jul 28, 2020

By : Team ABLE

Moderna to expand BARDA agreement to support larger phase 3 program for Covid-19 vaccine

BARDA will extend an additional commitment of up to $472 million to support late stage clinical development including the expanded Phase 3 study of the Moderna’s mRNA vaccine candidate (mRNA-1273) against COVID-19.

Jul 28, 2020

By : Team ABLE

GSK and CureVac announce strategic mRNA technology collaboration

Companies will collaborate on mRNA vaccine and monoclonal antibody research programmes in infectious diseases

Jul 28, 2020

By : Team ABLE

Delhi’s APAC Biotech bags patent for personalized immunotherapy based cancer treatment

APCEDEN – APAC’s immunotherapy product, has already been approved by the Indian FDA for treating cancer. The company has further announced it will conduct clinical trials for highly aggressive brain tumors

Jul 28, 2020

By : Team ABLE